Non-cell-autonomous tumor suppression by p53

Cell

Volumn 153, Issue 2, 2013, Pages 449-460

  Lujambio, Amaia ^a,b   Akkari, Leila ^b   Simon, Janelle ^a,b,d   Grace, Danielle ^a,b   Tschaharganeh, Darjus F ^b   Bolden, Jessica E ^a,b   Zhao, Zhen ^a,b   Thapar, Vishal ^a,b   Joyce, Johanna A ^b   Krizhanovsky, Valery ^a,c   Lowe, Scott W ^a,b,d  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL AGING; CELL CYCLE ARREST; CELL FUNCTION; CELL POLARITY; CELL PROLIFERATION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STELLATE CELL;

EID: 84876291823     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.03.020     Document Type: Article

References (47)

1. J.C. Acosta, A. O'Loghlen, A. Banito, M.V. Guijarro, A. Augert, S. Raguz, M. Fumagalli, M. Da Costa, C. Brown, and N. Popov Chemokine signaling via the CXCR2 receptor reinforces senescence Cell 133 2008 1006 1018
2. R. Bataller, and D.A. Brenner Liver fibrosis J. Clin. Invest. 115 2005 209 218
3. S.K. Biswas, and A. Mantovani Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm Nat. Immunol. 11 2010 889 896
4. J. Campisi, and F. d'Adda di Fagagna Cellular senescence: when bad things happen to good cells Nat. Rev. Mol. Cell Biol. 8 2007 729 740
5. Y. Chien, C. Scuoppo, X. Wang, X. Fang, B. Balgley, J.E. Bolden, P. Premsrirut, W. Luo, A. Chicas, and C.S. Lee Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity Genes Dev. 25 2011 2125 2136
6. M. Collado, and M. Serrano Senescence in tumours: evidence from mice and humans Nat. Rev. Cancer 10 2010 51 57
7. J.P. Coppé, C.K. Patil, F. Rodier, Y. Sun, D.P. Muñoz, J. Goldstein, P.S. Nelson, P.Y. Desprez, and J. Campisi Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor PLoS Biol. 6 2008 2853 2868
8. E. Crescenzi, F. Pacifico, A. Lavorgna, R. De Palma, E. D'Aiuto, G. Palumbo, S. Formisano, and A. Leonardi NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells Oncogene 30 2011 2707 2717
9. K.M. Dameron, O.V. Volpert, M.A. Tainsky, and N. Bouck Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 Science 265 1994 1582 1584
10. J.S. Duffield, S.J. Forbes, C.M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang, and J.P. Iredale Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair J. Clin. Invest. 115 2005 56 65
11. P.E. Forni, C. Scuoppo, I. Imayoshi, R. Taulli, W. Dastrù, V. Sala, U.A. Betz, P. Muzzi, D. Martinuzzi, and A.E. Vercelli High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly J. Neurosci. 26 2006 9593 9602
12. A.L. Fridman, and M.A. Tainsky Critical pathways in cellular senescence and immortalization revealed by gene expression profiling Oncogene 27 2008 5975 5987
13. M. Hesse, A.W. Cheever, D. Jankovic, and T.A. Wynn NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease Am. J. Pathol. 157 2000 945 955
14. R. Hill, Y. Song, R.D. Cardiff, and T. Van Dyke Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis Cell 123 2005 1001 1011
15. H. Jing, J. Kase, J.R. Dörr, M. Milanovic, D. Lenze, M. Grau, G. Beuster, S. Ji, M. Reimann, and P. Lenz Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations Genes Dev. 25 2011 2137 2146
16. T.W. Kang, T. Yevsa, N. Woller, L. Hoenicke, T. Wuestefeld, D. Dauch, A. Hohmeyer, M. Gereke, R. Rudalska, and A. Potapova Senescence surveillance of pre-malignant hepatocytes limits liver cancer development Nature 479 2011 547 551
17. H. Kiaris, I. Chatzistamou, G. Trimis, M. Frangou-Plemmenou, A. Pafiti-Kondi, and A. Kalofoutis Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis Cancer Res. 65 2005 1627 1630
18. X. Kong, D. Feng, H. Wang, F. Hong, A. Bertola, F.S. Wang, and B. Gao Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice Hepatology 56 2012 1150 1159
19. A. Krtolica, S. Parrinello, S. Lockett, P. Desprez, and J. Campisi Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging Proc. Natl. Acad. Sci. USA 98 2001 12072 12077
20. V. Krizhanovsky, M. Yon, R.A. Dickins, S. Hearn, J. Simon, C. Miething, H. Yee, L. Zender, and S.W. Lowe Senescence of activated stellate cells limits liver fibrosis Cell 134 2008 657 667
21. T. Kuilman, C. Michaloglou, L.C. Vredeveld, S. Douma, R. van Doorn, C.J. Desmet, L.A. Aarden, W.J. Mooi, and D.S. Peeper Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network Cell 133 2008 1019 1031
22. K. Kurose, K. Gilley, S. Matsumoto, P.H. Watson, X.P. Zhou, and C. Eng Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas Nat. Genet. 32 2002 355 357
23. J.S. Lee, I.S. Chu, A. Mikaelyan, D.F. Calvisi, J. Heo, J.K. Reddy, and S.S. Thorgeirsson Application of comparative functional genomics to identify best-fit mouse models to study human cancer Nat. Genet. 36 2004 1306 1311
24. T. Li, N. Kon, L. Jiang, M. Tan, T. Ludwig, Y. Zhao, R. Baer, and W. Gu Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence Cell 149 2012 1269 1283
25. S. Marino, M. Vooijs, H. van Der Gulden, J. Jonkers, and A. Berns Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum Genes Dev. 14 2000 994 1004
26. K. Movahedi, D. Laoui, C. Gysemans, M. Baeten, G. Stangé, J. Van den Bossche, M. Mack, D. Pipeleers, P. In't Veld, P. De Baetselier, and J.A. Van Ginderachter Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes Cancer Res. 70 2010 5728 5739
27. W.E. Naugler, T. Sakurai, S. Kim, S. Maeda, K. Kim, A.M. Elsharkawy, and M. Karin Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 2007 121 124
28. F. Oakley, J. Mann, S. Nailard, D.E. Smart, N. Mungalsingh, C. Constandinou, S. Ali, S.J. Wilson, H. Millward-Sadler, J.P. Iredale, and D.A. Mann Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury Am. J. Pathol. 166 2005 695 708
29. T. Ohtsuka, H. Ryu, Y.A. Minamishima, S. Macip, J. Sagara, K.I. Nakayama, S.A. Aaronson, and S.W. Lee ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway Nat. Cell Biol. 6 2004 121 128
30. P.K. Premsrirut, L.E. Dow, S.Y. Kim, M. Camiolo, C.D. Malone, C. Miething, C. Scuoppo, J. Zuber, R.A. Dickins, and S.C. Kogan A rapid and scalable system for studying gene function in mice using conditional RNA interference Cell 145 2011 145 158
31. B.Z. Qian, and J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 2010 39 51
32. P. Ramachandran, A. Pellicoro, M.A. Vernon, L. Boulter, R.L. Aucott, A. Ali, S.N. Hartland, V.K. Snowdon, A. Cappon, and T.T. Gordon-Walker Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis Proc. Natl. Acad. Sci. USA 109 2012 E3186 E3195
33. M. Reimann, S. Lee, C. Loddenkemper, J.R. Dörr, V. Tabor, P. Aichele, H. Stein, B. Dörken, T. Jenuwein, and C.A. Schmitt Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence Cancer Cell 17 2010 262 272
34. K.M. Ryan, M.K. Ernst, N.R. Rice, and K.H. Vousden Role of NF-kappaB in p53-mediated programmed cell death Nature 404 2000 892 897
35. C. Tanikawa, Y. Furukawa, N. Yoshida, H. Arakawa, Y. Nakamura, and K. Matsuda XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway Oncogene 28 2009 3081 3092
36. A.J. Trimboli, C.Z. Cantemir-Stone, F. Li, J.A. Wallace, A. Merchant, N. Creasap, J.C. Thompson, E. Caserta, H. Wang, and J.L. Chong Pten in stromal fibroblasts suppresses mammary epithelial tumours Nature 461 2009 1084 1091
37. K.H. Vousden, and C. Prives Blinded by the light: the growing complexity of p53 Cell 137 2009 413 431
38. W. Xue, L. Zender, C. Miething, R.A. Dickins, E. Hernando, V. Krizhanovsky, C. Cordon-Cardo, and S.W. Lowe Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Nature 445 2007 656 660
39. L. Zender, W. Xue, J. Zuber, C.P. Semighini, A. Krasnitz, B. Ma, P. Zender, S. Kubicka, J.M. Luk, and P. Schirmacher An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer Cell 135 2008 852 864
40. D.Y. Zhang, and S.L. Friedman Fibrosis-dependent mechanisms of hepatocarcinogenesis Hepatology 56 2012 769 775
41. H.W. Zimmermann, S. Seidler, N. Gassler, J. Nattermann, T. Luedde, C. Trautwein, and F. Tacke Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis PLoS ONE 6 2011 e21381
42. D.H. Dapito, A. Mencin, G.Y. Gwak, J.P. Pradere, M.K. Jang, I. Mederacke, J.M. Caviglia, H. Khiabanian, A. Adeyemi, and R. Bataller Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4 Cancer Cell 21 2012 504 516
43. A. Geerts, C. Eliasson, T. Niki, A. Wielant, F. Vaeyens, and M. Pekny Formation of normal desmin intermediate filaments in mouse hepatic stellate cells requires vimentin Hepatology 33 2001 177 188
44. T. Shree, O.C. Olson, B.T. Elie, J.C. Kester, A.L. Garfall, K. Simpson, K.M. Bell-McGuinn, E.C. Zabor, E. Brogi, and J.A. Joyce Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer Genes Dev. 25 2011 2465 2479
45. J.C. Sun, J.N. Beilke, N.A. Bezman, and L.L. Lanier Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection J. Exp. Med. 208 2011 357 368
46. L. Zender, M.S. Spector, W. Xue, P. Flemming, C. Cordon-Cardo, J. Silke, S.T. Fan, J.M. Luk, M. Wigler, and G.J. Hannon Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach Cell 125 2006 1253 1267
47. J. Zuber, J. Shi, E. Wang, A.R. Rappaport, H. Herrmann, E.A. Sison, D. Magoon, J. Qi, K. Blatt, and M. Wunderlich RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Nature 478 2011 524 528